poly adp-ribose polymerase (parp) inhibitor market segments

• Healthcare

Poly ADP-Ribose Polymerase (PARP) Inhibitor Global Market By Drug Type, By Application, By Distribution Channel, By Regional Forecast 2024-2033 | Pfizer Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A.

Overview and Scope Poly ADP-ribose polymerase (PARP) inhibitors are a class of pharmacological inhibitors that block the enzyme PARP, which…